Skip to main content
Fig. 16 | Biomaterials Research

Fig. 16

From: Emerging biomaterials for tumor immunotherapy

Fig. 16

STB-mediated ICB for tumor immunotherapy. A Schematic illustration of STB-mediated ICB. B Antitumor efficacy of STB-ICI. (a) Gross appearances of the tumors. (b) Survival rate analysis. (c) Tumor growth curve. (d) Tumor weight at the day of sacrifice (day 10 post operation) (Reproduced with permission from [118] Copyright © 2022, American Chemical Society)

Back to article page

Biomaterials Research

ISSN: 2055-7124

Contact us